Search tips
Search criteria 


Logo of oncotargetLink to Publisher's site
Oncotarget. 2017 February 7; 8(6): 10760.
Published online 2017 February 6. doi:  10.18632/oncotarget.15112
PMCID: PMC5354698

Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells

Present: Due to an error during figure assembly, the center panel of Figure Figure2B2B was prepared using the wrong set of blots.

Figure 2
Lapatinib induces apoptosis in association with downregulation of CIP2A and p-Akt in TNBC cells

Corrected: The corrected Figure Figure22 is shown below. The authors sincerely apologize for this oversight.

Original article: Oncotarget. 2016; 7(8):9135-49. doi: 10.18632/oncotarget.7035.

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC